ARN-509

This Week in Biotech
Motley Fool
Sun, 06/23/13 - 11:11 am
Nektar
NKTR-181
pain management
Novartis
serelaxin
Idenix
IDX20963
hepatitis C
ViroPharma
JNJ
Aragon
ARN-509
prostage cancer
J&J to Buy Aragon Pharmaceuticals for Cancer Candidate
Bloomberg
Mon, 06/17/13 - 09:15 am
Aragon
JNJ
M&A
ARN-509
prostate cancer
Aragon Pharma's ARN-509 Is No Near-Term Threat to Medivation
Yahoo/Minyanville
Tue, 04/23/13 - 03:30 pm
Medivation
Aragon
ARN-509
prostate cancer